Recipient Selection in DCD Liver Transplantation

Author(s):  
Humberto Bohorquez ◽  
Ari J. Cohen ◽  
George E. Loss
2009 ◽  
Vol 15 (11) ◽  
pp. 1586-1593 ◽  
Author(s):  
Charbel Sandroussi ◽  
Michael Crawford ◽  
David S. Lockwood ◽  
Patrick Tang ◽  
James P. Gallagher ◽  
...  

2018 ◽  
Vol 102 (5) ◽  
pp. 775-782 ◽  
Author(s):  
Giovanni Giretti ◽  
Louise Barbier ◽  
Petru Bucur ◽  
Frédéric Marques ◽  
Jean-Marc Perarnau ◽  
...  

Author(s):  
M. N. Kornilov ◽  
M. G. Minina ◽  
I. A. Miloserdov ◽  
D. N. Kruglov ◽  
R. S. Chaikin ◽  
...  

Orthotopic liver transplantation is the only way to cure chronic liver failure and certain liver tumors. Deceased donor organs are the prevailing source in most transplantation centers. However, there is an organ shortage because of the increasing number of patients in need of transplantation. Using expanded criteria deceased donors is a routine way to overcome organ shortage. The majority of transplantation centers take older donors depending on the local rules. Successful liver transplantation from 73-year-old deceased donor. Recipient suffered from liver neuroendocrine tumor without signs of extrahepatic spread. Liver function is adequate during 90-day follow-up. Liver transplantation from older deceased donors has good outcome according to world experience. Careful donor-recipient selection is the key to success. The first positive trial in our center enlightens the way for further practice.


2013 ◽  
Vol 59 (5) ◽  
pp. 261-263
Author(s):  
Piros L ◽  
Görög D ◽  
Fehérvári I ◽  
Nemes B ◽  
Langer R ◽  
...  

AbstractBackground: Liver transplantation for hepatic tumours is known as a proven treatment opportunity. The outcome has improved over the past decades because of the appropriate recipient selection. Materials and methods: In a single-institution study of 29 consecutive adult patients underwent orthotopic liver transplantation (OLT) between 1 January 2004 and 1 January 2011 in the Semmelweis University, Budapest with the indication of hepatocellular carcinoma (HCC). Results: The 1-year survival was 85.7% and the 3-year survival was 71.7%. Conclusions: Further investigations are needed on the field of histological and biological attributes of the hepatocellular carcinoma. Our aim is to find a better and individualized immunosuppressive protocol, which is also protective against malignant tumours


2022 ◽  
Author(s):  
Yuki Bekki ◽  
Bryan Myers ◽  
Ryan Wang ◽  
Natalie Smith ◽  
Jeron Zerillo ◽  
...  

2021 ◽  
Vol 105 (9) ◽  
pp. 1892-1903
Author(s):  
Andrea Schlegel ◽  
David P. Foley ◽  
Eric Savier ◽  
Mauricio Flores Carvalho ◽  
Luciano De Carlis ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document